📰 Trial Making Test News
Trial Making Test News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Trial Making Test. Real-time updates on events, politics, business and more.
October 25, 2023
While the trial was designed to test safety and not efficacy, patients treated with Araclon Biotech’s experimental ABvac40 vaccine saw a 38% drop in disease progression compared to placebo.
October 24, 2023
Trial met primary endpoints, confirming vaccine’s safety, tolerability and robust immune response against the Aβ40 peptide in early-stage Alzheimers...
April 19, 2022
Pediatric patients with multiple sclerosis showed a reduced resting-state functional connectivity (RS-FC) in language, memory, and motor networks.
April 6, 2022
Pediatric patients with multiple sclerosis showed a reduced resting-state functional connectivity (RS-FC) in language, memory, and motor networks.